This guest commentary is written by Robert Goria, Chief Trade Strategy Officer, CarePartners Pharmacy. The article addresses a practical approach to navigating biosimilar substitution, as we may soon be seeing significant change in the meaning of interchangeability for biosimilars. The US biologics market is undergoing a quiet but consequential shift. Years after the Biologics Price … Continue reading Navigating Biosimilar Substitution